Projects per year
Personal profile
Education
- 國立成功大學 公衛所 博士
- 國立成功大學 醫學系 學士
Experience
- 成大醫院內科部胸腔科科主任
- 成大醫院內科部主治醫師
- 成大醫學院內科學科副教授
- 胸腔暨重症醫學專科指導醫師
- 內科專科指導醫師
- 南區結核病審委員
- 成大醫院斗六分院主治醫師
- 耶魯大學博士後研究
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 8 Decent Work and Economic Growth
Fingerprint
Dive into the research topics where Szu-Chun Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prioritizing Lung Cancer Treatments for Comparative Effectiveness and Cost-Effectiveness Analyses
Yang, S.-C. (PI)
25-08-01 → 26-07-31
Project: Research project
-
Prioritizing Lung Cancer Treatments for Comparative Effectiveness and Cost-Effectiveness Analyses
Yang, S.-C. (PI)
27-08-01 → 28-07-31
Project: Research project
-
Prioritizing Lung Cancer Treatments for Comparative Effectiveness and Cost-Effectiveness Analyses
Yang, S.-C. (PI)
26-08-01 → 27-07-31
Project: Research project
-
Cost-Effectiveness Analysis of Multiple Immunotherapy Combinations and Gene Testing Strategies for Lung Cancer
Yang, S.-C. (PI)
24-08-01 → 25-07-31
Project: Research project
-
Cost-Effectiveness Analysis of Multiple Immunotherapy Combinations and Gene Testing Strategies for Lung Cancer
Yang, S.-C. (PI)
23-08-01 → 24-07-31
Project: Research project
-
Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma (PharmacoEconomics, (2025), 43, 4, (429-440), 10.1007/s40273-024-01462-z)
Ou, H. T., Tsai, J. H., Chen, Y. L., Wu, T. I., Chen, L. J. & Yang, S. C., 2026 Feb, In: PharmacoEconomics. 44, 2, p. 261 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Treatment Patterns Across Lines of Therapy for Advanced Non-Small Cell Lung Cancer in the United States
Lee, D. H., Li, Y., Yang, S. C., Chiang, A. C., Soulos, P. R., Gross, C. P. & Wang, S. Y., 2026 Apr, In: Cancer medicine. 15, 4, e71736.Research output: Contribution to journal › Article › peer-review
Open Access -
Biomarker-Specific Survival and Medication Cost for Patients with Non-Small Cell Lung Cancer
Tan, J., Yang, S. C., Dinan, M. A., Chiang, A. C., Gross, C. P. & Wang, S. Y., 2025, (Accepted/In press) In: JAMA network open. p. e2514519Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Limited-Stage SCLC
Tsai, S.-H., Tsai, J.-H., Chen, L. J. & Yang, S. C., 2025 Nov, In: JTO Clinical and Research Reports. 6, 11, 100879.Research output: Contribution to journal › Article › peer-review
Open Access -
Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma
Ou, H. T., Tsai, J. H., Chen, Y. L., Wu, T. I., Chen, L. J. & Yang, S. C., 2025 Apr, In: PharmacoEconomics. 43, 4, p. 429-440 12 p., e2200201.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus)